With ReFlow® EVD, Anuncia is advancing both acute and long ... clinical evidence for hydrocephalus patients at high risk for shunt occlusion, including those affected by Coccidioidomycosis ...

Once his condition stabilised, Doctors removed the EVD and performed a fresh VP shunt surgery on the opposite side of his brain. The child made a full recovery and was discharged two days after ...

Anuncia Medical, Inc. ("Anuncia"), a pioneering company in CSF management and neurocritical care, has received Breakthrough ...